Ironwood Pharmaceuticals Operating Income 2009-2020 | IRWD

Ironwood Pharmaceuticals operating income from 2009 to 2020. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Ironwood Pharmaceuticals Annual Operating Income
(Millions of US $)
2019 $120
2018 $-151
2017 $-15
2016 $-52
2015 $-102
2014 $-169
2013 $-252
2012 $-73
2011 $-66
2010 $-61
2009 $-61
2008 $-48
2007 $-58
2006 $-40
Ironwood Pharmaceuticals Quarterly Operating Income
(Millions of US $)
2020-03-31 $13
2019-12-31 $50
2019-09-30 $66
2019-06-30 $22
2019-03-31 $-17
2018-12-31 $46
2018-09-30 $-147
2018-06-30 $-15
2018-03-31 $-36
2017-12-31 $85
2017-09-30 $-19
2017-06-30 $-41
2017-03-31 $-40
2016-12-31 $-6
2016-09-30 $-28
2016-06-30 $-15
2016-03-31 $-2
2015-12-31 $-6
2015-09-30 $-26
2015-06-30 $-42
2015-03-31 $-28
2014-12-31 $-33
2014-09-30 $-37
2014-06-30 $-55
2014-03-31 $-44
2013-12-31 $-47
2013-09-30 $-57
2013-06-30 $-60
2013-03-31 $-89
2012-12-31 $-44
2012-09-30 $48
2012-06-30 $-41
2012-03-31 $-36
2011-12-31 $-7
2011-09-30 $-22
2011-06-30 $-19
2011-03-31 $-19
2010-12-31 $-13
2010-09-30 $-16
2010-06-30 $-17
2010-03-31 $-14
2009-12-31 $-15
2009-09-30 $-8
2009-06-30 $-19
2009-03-31 $-19
2008-12-31
2008-09-30
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.602B $0.428B
Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. The Company's first in class compound, Linaclotide, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with constipation and chronic constipation. The Company also focuses on one Phase 1 pain drug candidate and multiple preclinical programs, as well as on building a specialty biochemicals business based on a proprietary strain-development platform. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $67.693B 38.42
Takeda Pharmaceutical (TAK) Japan $60.060B 10.52
Astellas Pharma (ALPMY) Japan $33.206B 16.58
Eisai (ESALY) Japan $23.933B 44.59
UCB SA (UCBJF) Belgium $19.548B 0.00
Merck (MKGAF) Germany $15.425B 20.23
Grifols, S.A (GRFS) Spain $13.538B 16.83
Catalent (CTLT) United States $12.243B 47.33
Neurocrine Biosciences (NBIX) United States $11.054B 51.09
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Ionis Pharmaceuticals (IONS) United States $7.916B 42.09
Orion OYJ (ORINY) Finland $7.289B 32.66
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.270B 0.00
IPSEN SA ADR (IPSEY) France $6.744B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.570B 10.52
United Therapeutics (UTHR) United States $5.532B 10.48
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Hypermarcas (HYPMY) Brazil $4.239B 12.89
Evotec AG (EVTCY) Germany $4.117B 66.40
Nektar Therapeutics (NKTR) United States $4.028B 0.00
ChemoCentryx (CCXI) United States $3.747B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.258B 355.67
PTC Therapeutics (PTCT) United States $3.139B 0.00
FibroGen (FGEN) United States $2.958B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.612B 10.74
Cronos Group (CRON) Canada $2.253B 64.60
Pacira BioSciences (PCRX) United States $1.943B 39.76
Sage Therapeutics (SAGE) United States $1.869B 0.00
USANA Health Sciences (USNA) United States $1.807B 18.53
Xencor (XNCR) United States $1.703B 0.00
Heron Therapeutics (HRTX) United States $1.700B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.686B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.681B 0.00
Corcept Therapeutics (CORT) United States $1.662B 16.48
Zogenix (ZGNX) United States $1.645B 0.00
Akebia Therapeutics (AKBA) United States $1.548B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.434B 15.45
Portola Pharmaceuticals (PTLA) United States $1.407B 0.00
Karyopharm Therapeutics (KPTI) United States $1.287B 0.00
Tilray (TLRY) Canada $1.257B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.224B 0.00
Esperion Therapeutics (ESPR) United States $1.165B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.019B 45.49
Translate Bio (TBIO) United States $1.016B 0.00
Endo (ENDP) Ireland $0.919B 1.42
ImmunoGen (IMGN) United States $0.825B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.794B 0.00
Molecular Templates (MTEM) United States $0.734B 0.00
Indivior (INVVY) United States $0.731B 9.07
Collegium Pharmaceutical (COLL) United States $0.721B 0.00
Aerie Pharmaceuticals (AERI) United States $0.705B 0.00
Ardelyx (ARDX) United States $0.622B 0.00
Trillium Therapeutics (TRIL) Canada $0.617B 0.00
Radius Health (RDUS) United States $0.584B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.523B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.507B 0.00
Innate Pharma SA (IPHYF) France $0.489B 0.00
Siga Technologies (SIGA) United States $0.484B 0.00
DURECT (DRRX) United States $0.480B 0.00
Flexion Therapeutics (FLXN) United States $0.469B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.460B 11.13
Organogenesis Holdings (ORGO) United States $0.447B 0.00
Harpoon Therapeutics (HARP) United States $0.431B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.429B 16.77
MEI Pharma (MEIP) United States $0.401B 0.00
Calithera Biosciences (CALA) United States $0.380B 0.00
Ocular Therapeutix (OCUL) United States $0.369B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.340B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.315B 0.00
TherapeuticsMD (TXMD) United States $0.304B 0.00
Lannett Co Inc (LCI) United States $0.301B 6.61
Avadel Pharmaceuticals (AVDL) Ireland $0.300B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.288B 0.00
Concert Pharmaceuticals (CNCE) United States $0.275B 0.00
CASI Pharmaceuticals (CASI) United States $0.267B 0.00
Rafael Holdings (RFL) United States $0.253B 0.00
Redhill Biopharma (RDHL) Israel $0.246B 0.00
OptiNose (OPTN) United States $0.232B 0.00
KalVista Pharmaceuticals (KALV) United States $0.207B 0.00
VAXART, INC (VXRT) United States $0.203B 0.00
PROFOUND MEDICL (PROF) Canada $0.201B 0.00
Nature's Sunshine Products (NATR) United States $0.192B 25.26
Jounce Therapeutics (JNCE) United States $0.191B 4.56
IMV INC (IMV) Canada $0.178B 0.00
Aquestive Therapeutics (AQST) United States $0.178B 0.00
Taiwan Liposome (TLC) Taiwan $0.178B 0.00
Xeris Pharmaceuticals (XERS) United States $0.172B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.170B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.135B 0.00
Altimmune (ALT) United States $0.129B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.116B 0.00
Recro Pharma (REPH) United States $0.109B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.105B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.104B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.103B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.091B 0.00
Sundial Growers (SNDL) Canada $0.088B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.088B 0.00
Otonomy (OTIC) United States $0.084B 0.00
CTI BioPharma (CTIC) United States $0.081B 0.00
SCYNEXIS (SCYX) United States $0.080B 0.00
Onconova Therapeutics (ONTX) United States $0.078B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.076B 0.00
Nivalis Therapeutics (ALPN) United States $0.076B 0.00
CV Sciences (CVSI) United States $0.075B 0.00
Hemispherx BioPharma (AIM) United States $0.074B 0.00
Heat Biologics (HTBX) United States $0.070B 0.00
Aclaris Therapeutics (ACRS) United States $0.060B 0.00
Biomerica (BMRA) United States $0.060B 0.00
MediWound (MDWD) Israel $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.056B 0.00
Infinity Pharmaceuticals (INFI) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.55
Opiant Pharmaceuticals (OPNT) United States $0.049B 105.00
IsoRay (ISR) United States $0.048B 0.00
Natural Alternatives (NAII) United States $0.048B 0.00
GTx (ONCT) United States $0.044B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.043B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.042B 0.00
Lipocine (LPCN) United States $0.042B 0.00
PolarityTE (PTE) United States $0.042B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.040B 0.00
Addex Therapeutics (ADXN) Switzerland $0.040B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Mannatechorporated (MTEX) United States $0.038B 7.26
Adamis Pharmaceuticals (ADMP) United States $0.037B 0.00
Neos Therapeutics (NEOS) United States $0.037B 0.00
AgeX Therapeutics (AGE) United States $0.036B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Novan (NOVN) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.027B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Can-Fite Biopharma (CANF) Israel $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.016B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Vical (BBI) United States $0.011B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
HANCOCK JAFFE (HJLI) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00